Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, December 20, 2013
OsoBio has reaffirmed its long-standing partnership with the Drug, Chemical and Associated Technologies Association (DCAT) by accepting new volunteer leadership positions within the organization.
read more
Thursday, February 21, 2013
OsoBio President Milton Boyer will serve on a panel of experts examining shortages of injectable pharmaceuticals during DCAT Week.
read more
Otonomy announced a license agreement with KYORIN that provides exclusive worldwide rights to develop, manufacture and commercialize a novel compound for sensorineural hearing loss.
read more
Friday, December 22, 2017
Otsuka Pharmaceutical and X-Chem have signed a collaborative research agreement to advance the discovery process for new Otsuka drug compounds.
read more
The current global discovery outsourcing market of cancer immunotherapy is about $2.8 B. In the past five years (2010 - 2014), its CAGR was about 37%. Based on analysis, Research and Markets forecast that the global cancer immunotherapy-focused drug ...
read more
Tuesday, October 11, 2022
The Outsourcing Facilities Association (OFA) announced that it has reached a settlement agreement with the FDA that spurs the FDA to promptly review long-pending nominations for active pharmaceutical ingredients for use by FDA-registered outsourcing ...
read more
Wednesday, November 06, 2013
The strategies and timing of outsourcing pharmaceutical development processes to a contract testing laboratory will be the focus of a mini-workshop at the 2013 AAPS Annual Meeting and Exposition on Nov. 12, 2013.
read more
Wednesday, August 12, 2020
CluePoints announced the success of its complimentary COVID-19 risk management package alongside comprehensive support for COVID-19 affected trials.
read more
Ovid Therapeutics announced a strategic research collaboration with Columbia University Irving Medical Center researchers to advance genetic based therapies for a range of rare neurological conditions.
read more
Ovid and Angelini Pharma have announced an agreement in which Angelini will be responsible to develop, manufacture and commercialize OV101 (gaboxadol).
read more
Angelini Pharma will be responsible to develop, manufacture and commercialize OV101 for the potential treatment of Angelman syndrome.
read more
Indian pharmacovigilance consulting and drug safety services company Oviya MedSafe Pvt Ltd has
signed an agreement with British software development company Assured Information Systems Ltd to
combine the former's drug safety services with the ...
read more
OWP Pharmaceuticals has chosen EVERSANA to provide commercialization support for the U.S. launch of SUBVENITE® (lamotrigine) oral suspension, a recently FDA-approved treatment for epilepsy and bipolar disorders.
read more
Tuesday, October 07, 2025
OXB, a cell and gene therapy CDMO, has signed and closed an asset purchase transaction to acquire a custom-built, state-of-the-art cell and gene therapy viral vector manufacturing facility in North Carolina from RTP Operating, LLC, a subsidiary of ...
read more
Oxeltis and Molecular Forecaster Inc. (MFI), a computational chemistry company, announced a strategic partnership, leveraging the strengths of both organizations to offer the seamless integration of in silico design with high-quality chemical ...
read more